ADELAIDE, Australia, May 26, 2025 (GLOBE NEWSWIRE) — As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.Read More

You might also be interested in reading PwC deepens crypto push as U.S. rules shift and stablecoins go mainstream: Report.